| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |